Científicos de OHSU recibieron fondos para extender investigación de vanguardia
OHSU scientists awarded funding to extend leading-edge research
beneficia con un ensayo clinico en etapa inicial de Oregon Health _ Science University 7
A la izquierda, Shivaani Kummar, M.D., FACP, codirectora adjunta del Knight Cancer Institute de OHSU, jefa de la División de Hematología y Oncología Médica de la Facultad de Medicina de OHSU y codirectora del Centro de Terapéutica Experimental del Knight Cancer Institute. habla con el director del Instituto Knight contra el Cáncer de OHSU, Brian Druker, M.D., en la inauguración de la unidad de ensayos clínicos de fase temprana de OHSU en el Centro para la Salud y la Curación del Edificio 2 en el campus de South Waterfront de OHSU, el 23 de agosto de 2021. (OHSU/Joe Rojas- Burke)
beneficia con un ensayo clnico en etapa inicial de Oregon Health _ Science University 5
Shivaani Kummar, M.D., head of the division of hematology and medical oncology in the OHSU School of Medicine, and Sanjay Malhotra, Ph.D., right, are co-directors of the Knight Cancer Institute’s Center for Experimental Therapeutics. (OHSU)
Early-phase clinical trial
Rhonda Stranz, 51, of Kelso, Washington, at a recent appointment at the OHSU Center for Health & Healing Building 2 in Portland. Stranz has benefited from an early-phase clinical trial at OHSU. (OHSU/Christine Torres Hicks)
Breast cancer clinical trial
Nurse practitioner Sandra Youngworth, D.N.P., left, and clinical research coordinator Vicki Abtin assist patient Rhonda Stranz at an appointment on Oct. 9. (OHSU/Christine Torres Hicks)
Breast cancer clinical trial
Rhonda Stranz and her daughter, Danlin Ortho, at the OHSU Center for Health & Healing Building 2 on Oct. 9. Stranz says: “I have faith that I’m going to see my daughter graduate high school in 2026,” she says. “She’s been my rock, and she has taken care of me through thick and thin. When they said I had less than year to live, I was feeling pretty sick. I have hope again.” (OHSU/Christine Torres Hicks)
Kummar and Druker
At left, Shivaani Kummar, M.D., FACP, co-deputy director of the OHSU Knight Cancer Institute, head of the Division of Hematology and Medical Oncology in the OHSU School of Medicine and co-director of the Knight Cancer Institute's Center for Experimental Therapeutics, talks with OHSU Knight Cancer Institute Director Brian Druker, M.D., at the opening of OHSU's early-phase clinical trial unit in the Center for Health and Healing Building 2 on OHSU's South Waterfront campus, Aug. 23, 2021. (OHSU/Joe Rojas-Burke)
OHSU breast cancer clinical trial
From left: Clinical research coordinator Vicki Abtin, nurse practitioner Sandra Youngworth, D.N.P., and senior clinical research assistant Meera Bhide with patient Rhonda Stranz. Stranz says: “If a clinical trial is recommended to you, consider participating in it. Trials are the future, in my opinion.” (OHSU/Christine Torres-Hicks)
OHSU breast cancer clinical trial
Meera Bhide, a senior clinical research assistant in the Knight Cancer Institute’s phase I clinical trial program, places electrocardiogram (ECG) leads on patient Rhonda Stranz in preparation to perform an ECG as part of her appointment. (OHSU/Christine Torres-Hicks)